Last reviewed · How we verify
Treatment 5
Treatment 5 is a Small molecule drug developed by EyeGene Inc.. It is currently FDA-approved. Also known as: Comparator.
Treatment 5 works by
ETC-1002 is a small molecule intervention being studied in clinical trials for various conditions, including hypercholesterolemia. It is being tested in combination with atorvastatin, a commonly used cholesterol-lowering medication, in a placebo-controlled study.
At a glance
| Generic name | Treatment 5 |
|---|---|
| Also known as | Comparator |
| Sponsor | EyeGene Inc. |
| Modality | Small molecule |
| Phase | FDA-approved |
Mechanism of action
Treatment 5 is a treatment that targets
Approved indications
Common side effects
Key clinical trials
- Dose-escalation of Regorafenib in Advanced Hepatocellular Carcinoma (PHASE2)
- A Study to Investigate the Efficacy, Safety, and Tolerability of DFV890 and MAS825 for Inflammatory Marker Reduction in Adult Participants With Coronary Heart Disease and Clonal Hematopoiesis of Indeterminate Potential (CHIP) (PHASE2)
- Phase I Trial of High-Density Theta Burst Stimulation (hdTBS) (PHASE1)
- Testing Palbociclib (PD-0332991) as a Potential Targeted Treatment in Cancers With CCND1, 2, 3 Amplification (MATCH-Subprotocol Z1B) (PHASE2)
- Testing the Addition of a New Anti-Cancer Drug, Triapine, to the Usual Chemotherapy Treatment (Cisplatin) During Radiation Therapy for Advanced-stage Cervical and Vaginal Cancers (PHASE3)
- Short-term Steroid Therapy in Patients With P. Jirovecii Pneumonia Due to HIV / AIDS (NA)
- Efficacy and Safety of Millet Seed Extract in Telogen Effluvium Treatment (NA)
- "Improving Health and Reducing Chronic Disease Risk in Middle-Aged Adults Through Nutrition" (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Treatment 5 CI brief — competitive landscape report
- Treatment 5 updates RSS · CI watch RSS
- EyeGene Inc. portfolio CI
Frequently asked questions about Treatment 5
What is Treatment 5?
How does Treatment 5 work?
Who makes Treatment 5?
Is Treatment 5 also known as anything else?
What development phase is Treatment 5 in?
Related
- Manufacturer: EyeGene Inc. — full pipeline
- Also known as: Comparator
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing